Aflibercept and Bevacizumab for Diabetic Maculopathies
Aflibercept and Bevacizumab for Diabetic Maculopathies
Recruiting · NCT06850571 · Registry updated 2025-09-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Aflibercept and Bevacizumab for Diabetic Maculopathies | Diabetic Maculopathy | Recruiting | Phase 4 | 2025-09-19 | NCT06850571 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Al-Mustansiriyah University | 14 |
| Baghdad Medical City | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Baghdad Medical City Complex | Baghdad | Iraq | 1 |